Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma. - Wikidata - awgldk - TriplyDB

Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma.

Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma.

http://www.wikidata.org/entity/Q35238250

about

Stem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open Questions Mesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunities Multifunctional nanoparticles for brain tumor imaging and therapy.Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapy Controlled Payload Release by Magnetic Field Triggered Neural Stem Cell Destruction for Malignant Glioma Treatment How stem cells speak with host immune cells in inflammatory brain diseases Stem cells as therapeutic vehicles for the treatment of high-grade gliomas.Neural stem cell-mediated intratumoral delivery of gold nanorods improves photothermal therapy.Analysis of glioblastoma tumor coverage by oncolytic virus-loaded neural stem cells using MRI-based tracking and histological reconstruction.A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma Tamoxifen improves cytopathic effect of oncolytic adenovirus in primary glioblastoma cells mediated through autophagy Unlocking the promise of oncolytic virotherapy in glioma: combination with chemotherapy to enhance efficacy Gene therapy for malignant glioma.Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model.Neural Stem Cells Secreting Anti-HER2 Antibody Improve Survival in a Preclinical Model of HER2 Overexpressing Breast Cancer Brain Metastases.Longitudinal evaluation of MPIO-labeled stem cell biodistribution in glioblastoma using high resolution and contrast-enhanced MR imaging at 14.1 tesla Three-dimensional assessment of bystander effects of mesenchymal stem cells carrying a cytosine deaminase gene on glioma cells.MMP14 as a novel downstream target of VEGFR2 in migratory glioma-tropic neural stem cells.The art of gene therapy for glioma: a review of the challenging road to the bedside Oncolytic virotherapy for malignant glioma: translating laboratory insights into clinical practice.Single dose GLP toxicity and biodistribution study of a conditionally replicative adenovirus vector, CRAd-S-pk7, administered by intracerebral injection to Syrian hamsters.A preclinical evaluation of neural stem cell-based cell carrier for targeted antiglioma oncolytic virotherapy.Drug-loaded nanoparticle systems and adult stem cells: a potential marriage for the treatment of malignant glioma?The timing of neural stem cell-based virotherapy is critical for optimal therapeutic efficacy when applied with radiation and chemotherapy for the treatment of glioblastoma Intranasal Oncolytic Virotherapy with CXCR4-Enhanced Stem Cells Extends Survival in Mouse Model of Glioma.N-acetylcysteine amide augments the therapeutic effect of neural stem cell-based antiglioma oncolytic virotherapy Neural stem cell-mediated delivery of irinotecan-activating carboxylesterases to glioma: implications for clinical use.Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies.Strategies in gene therapy for glioblastoma.Subventricular zone localized irradiation affects the generation of proliferating neural precursor cells and the migration of neuroblasts.Antiglioma oncolytic virotherapy: unattainable goal or a success story in the making?Glioblastoma multiforme: State of the art and future therapeutics.Cells as delivery vehicles for cancer therapeutics.Immune Suppression during Oncolytic Virotherapy for High-Grade Glioma; Yes or No?Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas.Use of genetically engineered stem cells for glioma therapy.Dynamic In Vivo SPECT Imaging of Neural Stem Cells Functionalized with Radiolabeled Nanoparticles for Tracking of Glioblastoma.Cell carriers for oncolytic viruses: current challenges and future directions.Encapsulated stem cells loaded with hyaluronidase-expressing oncolytic virus for brain tumor therapy.Neural stem cell-mediated delivery of oncolytic adenovirus.

P2860

Q26775038-AD3FCB7D-2F81-490C-BCE0-4FAA1965C282 Q26799013-E77DF97F-C110-4A1B-9FE0-02EC7F6A0A13 Q26865418-36F722B3-07B9-4498-AA6F-73FAD2D25CB2 Q26998111-AFB899AC-5521-4A64-B760-B9DBA31720E7 Q28552160-9FC416A3-9230-4C6E-AE83-29FD12AEB4E5 Q33776557-DA8EE18C-F942-49B2-BFEC-B213E8F906B6 Q34240433-F8CB0CC0-4556-4213-9F28-529D4E492D37 Q34782994-20BFF144-50E0-4D87-A490-4EBAF5A5D483 Q34943738-59C8EA09-AD5C-4CFE-B8CC-8C09178A6494 Q35256949-DE9241E9-C3D1-4542-85A5-A0370ABC993A Q35551921-0784FB8E-8DEB-4FCA-9006-03A8771DFB2F Q35657822-714B8F1E-4CDA-470A-9D0C-C31E1AACA89B Q35673628-3452D5FE-9A1A-4611-9D0E-8ADDA0DE5E65 Q35973436-48B7D8B3-7D2E-4447-82AA-AAA90FE872C3 Q36083446-29B46BA9-6D40-4BFC-AEEF-A4D2A17F6960 Q36127425-F001390E-63A9-4DB2-B6E4-0D24F1A34D1A Q36250616-001C007F-1A5E-4641-918C-2F8C964A9360 Q36421256-F16980E9-64C1-4AEE-A99D-945F996DEC15 Q36527593-17E23209-FB2C-4A0D-83A4-532ABC94F022 Q36634430-C0EE5D06-9DCC-49CA-BCA8-EE2E936AE71F Q36904198-DEF3BA1E-247F-4E1A-9D2E-684A4714533B Q36976226-198B4928-F456-438C-A7AF-90F5CD44ECE3 Q37029367-54B400D2-EC35-465E-A116-02AFBFEAD4CA Q37124552-116F3A58-0687-4247-B7B6-B2F53469FCD3 Q37274612-C9FE47D3-EAFF-4CD1-88EB-1D4A131B3AC2 Q37316856-177226CE-0B8C-45FA-9999-CAA8B2FBFB53 Q37344283-87059C78-5F52-45B4-80DC-32DAA8A4E4A3 Q37396577-5A62C245-8E8D-476A-B074-2BF6ECFE244E Q37420576-E02EA17F-4813-4BD2-871F-E76927EC7667 Q37709962-1866454C-4602-44FC-AA9D-3250FEAB7851 Q38218674-4EA20445-18D2-4D7C-A0F8-4F5EF524E5AC Q38225874-4B9E5E7A-A674-4FCA-9DF9-7EF22E130F5D Q38226664-50446ECF-529E-4F22-ACB4-93B3B89DDDBC Q38348844-F564DA5D-0535-4875-88DC-4EC47828D6F1 Q38715077-386C1FC5-A04D-41FE-ACAF-ECF7B2F12BAC Q38730790-3FC55A11-911B-4148-93EF-40011DB4150B Q38819741-C1B2C94D-B782-4248-AC10-2B4DB2289F3C Q38924531-CB3D4E5D-A7B6-4BD1-B746-97FD5D8DD77F Q38944271-6E422000-3E1F-4EF3-8431-DA4514977F2A Q39023173-9214890A-1829-4CC7-8C4B-5961142F0315

P2860

Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma.

http://www.wikidata.org/entity/Q35238250

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Neural stem cell-based cell ca ...... e model of human glioblastoma.

@ast

Neural stem cell-based cell ca ...... e model of human glioblastoma.

@en

type

label

Neural stem cell-based cell ca ...... e model of human glioblastoma.

@ast

Neural stem cell-based cell ca ...... e model of human glioblastoma.

@en

prefLabel

Neural stem cell-based cell ca ...... e model of human glioblastoma.

@ast

Neural stem cell-based cell ca ...... e model of human glioblastoma.

@en

P1433

Q35238250-63EA1586-88C2-4103-946B-EC33FFAB5F16

P1476

Q35238250-0E140BB4-152B-4439-80C9-DE424E60E30F

P2093

Q35238250-11DC2821-522D-43E6-9697-A692DF1AFA41

Q35238250-34B4871C-CEE4-44A6-9C17-0A3A9029651D

Q35238250-383C6E8E-B139-4C51-AAB8-769DF69BB085

Q35238250-4F14DE48-19FC-4E01-BD58-207ED8DD7A0E

Q35238250-511C9374-E0E4-4B34-94F9-2C9ADBCEF30A

Q35238250-8443F28A-407D-44D2-914D-644895D5E347

Q35238250-BCBA323E-1670-49C6-98E0-8EA98CF83389

Q35238250-D1E0372D-25DD-41AD-B658-3D21D8F86519

P2860

Q35238250-06FEC30B-4749-4B6D-AB53-4F474A7255B4

Q35238250-1422EF5E-6297-4120-9EBD-1AC627280C7C

Q35238250-1FCC3DDB-BB62-4AFA-8DEC-571E5D003A23

Q35238250-238FF609-3095-4E63-B758-F449D8980729

Q35238250-2B069B54-64A1-4799-B745-103A26155EF2

Q35238250-2BD43E89-DEE4-4D30-8B8F-583BBD82EC9C

Q35238250-317073FC-9644-4AF1-A22C-03F90B8AC5EB

Q35238250-447BB226-FEF1-4836-BE6B-A772DFD9E538

Q35238250-45428A6F-BE2E-4E53-87B7-C373EDCED9CF

Q35238250-4CD9D6D6-55BC-4B3A-9330-A5BEB3F5B4A3

P304

Q35238250-6A12836F-E021-4321-A841-E124689377AF

P31

Q35238250-1701A68B-0C1B-48B2-A556-048E4763C827

P356

Q35238250-364F3F91-AEB9-4EDD-9E82-B55FD36571C3

P433

Q35238250-3B39BE53-7EA3-4B8B-82E5-924A257C047B

P478

Q35238250-0BA721D7-BDAE-4539-A14D-86FC87318017

P50

Q35238250-08CB30B2-67B3-4440-8C5F-87D3A94159A1

Q35238250-4E2E2E35-E14B-4EB3-AF21-C0A4E70801EF

P577

Q35238250-E3C74627-0310-4B9E-8277-D8FDF542747F

P5875

Q35238250-304EC78F-C79F-44AE-B128-F14245C93F04

P698

Q35238250-327B79C7-369E-452E-A1C3-6B38E319393B

P921

Q35238250-04C5C384-B849-405C-BFC4-D691D82AC1B1

Q35238250-3E106F2E-F078-4932-88A1-2F27AB7A7192

P932

Q35238250-F9F556EF-F04D-492E-BD52-D398EB1EF010

P356

P1433

Molecular Therapy

P1476

Neural stem cell-based cell ca ...... se model of human glioblastoma

@en

P2093

Atique U Ahmed

http://www.w3.org/2001/XMLSchema#string

Feifei Liu

http://www.w3.org/2001/XMLSchema#string

Irina V Balyasnikova

http://www.w3.org/2001/XMLSchema#string

Karen S Aboody

http://www.w3.org/2001/XMLSchema#string

Maciej S Lesniak

http://www.w3.org/2001/XMLSchema#string

Nikita G Alexiades

http://www.w3.org/2001/XMLSchema#string

Shuo Qian

http://www.w3.org/2001/XMLSchema#string

Yu Han

http://www.w3.org/2001/XMLSchema#string

P2860

Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis.

Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury.

Virotherapy against malignant glioma stem cells

Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism.

Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas

The innate immune response to adenovirus vectors.

Striking out at disseminated metastases: the systemic delivery of oncolytic viruses.

Evaluation of E1A double mutant oncolytic adenovectors in anti-glioma gene therapy

Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo

Stem and progenitor cell-mediated tumor selective gene therapy.

P304

1714-1726

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2011.100

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51181037

http://www.w3.org/2001/XMLSchema#string

P698

21629227

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

3182345

http://www.w3.org/2001/XMLSchema#string